Form 4: Rani Therapeutics Holdings Director Buys Shares
Insider Transaction (Form 4)
Mir A Imran, a Director and 10% owner of Rani Therapeutics Holdings, Inc., purchased 36,000 shares of common stock on July 21, 2026 for $0.69 per share.
Summary
- Open-market purchase: acquired 36,000 Class A Common Stock at $0.69 ($24,840) on July 21, 2026; holds 2,119,334 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $24,840, committing personal capital to the stock.
Insider Transactions
Mir A Imran — Director, 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-21 | Open-market purchase | Class A Common Stock | 36,000 | $1 | $24.8K | 2,119,334 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-21 | Open-market purchase (36,000 shares) |
Keywords
insider transaction, Form 4, RANI, Rani Therapeutics Holdings, Inc., bullish, Mir A Imran
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.